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Objectives. This study sought to analyze the determinants of
pulmonary hypertension in patients with left ventricular dysfunc-
tion.
Background. Pulmonary hypertension in patients with left
ventricular dysfunction is a predictor of poor outcome. The
independent role of cardiac functional abnormalities in the gen-
esis of pulmonary hypertension is unclear.
Methods. In 102 consecutive patients with primary left ventric-
ular dysfunction (ejection fraction <50%), systolic pulmonary
artery pressure was prospectively measured by Doppler echocar-
diography (using tricuspid regurgitant velocity), and left ventric-
ular systolic and diastolic function, functional mitral regurgita-
tion, cardiac output and left atrial volume were quantified.
Results. Systolic pulmonary artery pressure was elevated in
patients with left ventricular dysfunction (51 6 14 mm Hg
[mean 6 SD]), but the range was wide (23 to 87 mm Hg). Of the
numerous variables correlating significantly with systolic pulmo-
nary artery pressure, the strongest were mitral deceleration time
(r 5 20.61, p 5 0.0001; odds ratio of pulmonary pressure
>250 mm Hg [95% confidence interval] if <150 ms, 48.8 [14.8 to
161]) and mitral effective regurgitant orifice (r5 0.50, p5 0.0001;
odds ratio [95% confidence interval] if >220 mm
2, 5.9 [2.3 to
15.5]). In multivariate analysis, these two variables were the
strongest predictors of systolic pulmonary artery pressure in
association with age (p 5 0.005). Ejection fraction or end-systolic
volume was not an independent predictor of pulmonary artery
pressure.
Conclusions. Pulmonary hypertension is frequent and highly
variable in patients with left ventricular dysfunction. It is not
independently related to the degree of left ventricular systolic
dysfunction but is strongly associated with diastolic dysfunction
(shorter mitral deceleration time) and the degree of functional
mitral regurgitation (larger effective regurgitant orifice). These
results emphasize the importance of assessing diastolic function
and quantifying mitral regurgitation in patients with left ventric-
ular dysfunction.
(J Am Coll Cardiol 1997;29:153–9)
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Congestive heart failure, a major cause of mortality (1,2) is due
mostly to left ventricular dysfunction (3). However, not all
patients with left ventricular dysfunction have heart failure,
and their functional tolerance (4) and hemodynamic profile (5)
may be widely variable and have important prognostic impli-
cations (6).
Specifically, pulmonary hypertension complicating left ven-
tricular dysfunction is associated with a high mortality and
incidence of heart failure (7) and an even worse outcome of
heart transplantation (8). Such a grim prognosis underscores
the importance of defining the determinants (9,10) of the
variable degree of pulmonary hypertension associated with left
ventricular dysfunction (11).
Recent studies (12–14) have suggested an association be-
tween abnormal left ventricular inflow velocity patterns as-
sessed by Doppler echocardiography and increased pulmonary
artery pressure in left ventricular dysfunction. However, in left
ventricular dysfunction, because of the frequent functional
mitral regurgitation (12–14) and the changes in left atrial
volume and compliance, which may affect left ventricular filling
patterns (15–17), the independent determinants of pulmonary
hypertension are unclear (14). These multiple intricate rela-
tions account for the limited comprehension of the variability
of the functional and hemodynamic consequences of left
ventricular dysfunction (18,19). Recent advances in noninva-
sive Doppler echocardiography allow the reliable assessment
of systolic pulmonary artery pressure (20), cardiac output (21),
left ventricular volume, systolic (22) and diastolic (23–25)
function, left atrial volume (26) and mitral regurgitation
(27,28) during a single examination and afford the possibility of
comprehending their independent relation in patients with left
ventricular dysfunction.
Therefore, we prospectively examined, using Doppler echo-
cardiography, patients with left ventricular dysfunction and
hypothesized that the degree of pulmonary hypertension 1)
varies widely, 2) is not independently related to the degree of
left ventricular dysfunction, but 3) is independently related to
both the severity of the diastolic filling abnormalities and the
degree of mitral regurgitation measured quantitatively.
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Methods
The study was conducted prospectively in the echocardio-
graphic laboratory in patients examined by the authors. Inclu-
sion criteria were 1) presence of left ventricular dysfunction as
defined by an ejection fraction ,50%; 2) systolic pulmonary
artery pressure measurable with Doppler echocardiography
using tricuspid regurgitant velocity; and 3) comprehensive
hemodynamic assessment with Doppler echocardiography, al-
lowing the measurements specified below.
Exclusion criteria were 1) presence of organic mitral or
aortic valvular disease; 2) presence of clinical, pathologic or
echocardiographic features of amyloidosis or constrictive peri-
carditis; 3) diagnosis of recent (,3 months) myocardial infarc-
tion; 4) clinical diagnosis of chronic obstructive pulmonary
disease or any identified primary pulmonary process indepen-
dent of left ventricular dysfunction; 5) presence of congenital
heart defects detectable with echocardiography; and 6) tachy-
arrhythmia of any type with a heart rate $120 beats/min.
Doppler echocardiography. A complete two-dimensional
Doppler echocardiographic examination was performed as
described previously (29,30). Left ventricular volumes were
measured using the biapical Simpson’s (disk method) rule as
recommended by the American Society of Echocardiography
(22). Left atrial volume was calculated using the biplane area
length method at end systole (26). Using pulsed wave Doppler
echocardiography, cardiac output was calculated as the prod-
uct of aortic stroke volume times heart rate (21). Mitral
regurgitation was quantified by two methods: quantitative
Doppler echocardiography using the Doppler measurement of
mitral and aortic stroke volumes (27,31) and quantitative
two-dimensional echocardiography using the measurement of
left ventricular volumes and stroke volume (27,32). This al-
lowed calculation of the regurgitant volume and fraction as
well as the effective regurgitant orifice as described previously
(28). In patients with no or trace mitral regurgitation by color
flow imaging, the regurgitant volume and fraction were used as
calculated, and the effective regurgitant orifice was assumed as
null. The variables of left ventricular diastolic inflow were
obtained using pulsed wave Doppler echocardiography by
positioning the sample volume at the tip of the mitral leaflets,
with measurement of the E and A wave (in sinus rhythm)
velocities, their ratio and the deceleration time of the E wave.
If the E and A waves were fused because of tachycardia,
carotid sinus massage was used to separate them, with the E
velocity returning almost to baseline (23,24). The tricuspid
regurgitant signal was recorded by continuous wave Doppler
echocardiography, and its maximal velocity was measured.
Right atrial pressure was estimated on the basis of the size and
inspiratory collapse of the inferior vena cava (33), and right
ventricular systolic pressure was calculated as described previ-
ously (20) and was assumed to be identical to the systolic
pulmonary artery pressure by demonstrating the absence of a
gradient on the pulmonary valve and normal morphology of
the right ventricular outflow tract.
Statistics. Results are presented as mean value 6 SD or
percentages. Group comparisons were performed using a
standard t test or chi-square test. Linear and Spearman rank
regressions were used with systolic pulmonary artery pressure
as the dependent variable and the clinical and hemodynamic
measurements in Table 1 as independent variables. Multivar-
iate analysis using stepwise forward multiple linear regression
was then performed using the original values or ranks of the
candidate independent variables (those with a significant uni-
variate correlation with systolic pulmonary artery pressure).
The candidate independent variables were grouped into three
categories. Category 1 included the variables of mitral regurgi-
tation (i.e., regurgitant volume, fraction and orifice), and
separate models were used for the two methods of measure-
ment of these variables. Category 2 included the variables of
diastolic function (E wave velocity, A wave velocity, E/A ratio
and mitral deceleration time). Category 3 included the rest of
the variables shown in Table 1. The analysis was performed
sequentially in category 1 and 2 variables and then combined
with category 3 variables in two final models (one for each
method of quantitation of regurgitation). These models were
also rerun with the tricuspid regurgitant velocity as the end
point. Only variables significant in both linear and rank models
were retained as independent determinants of pulmonary
hypertension. The entry criterion in the multivariate analysis
was p , 0.15, and p , 0.05 was considered significant.
Results
Baseline characteristics. The study included 102 patients
(mean age 68 6 13 years, range 12 to 89; 69 men [68%]).
Sixteen patients were in New York Heart Association func-
tional class I, 25 in class II, 44 in class III and 17 in class IV.
The baseline hemodynamic characteristics are presented in
Table 1. The mean ejection fraction was 30% 6 9% (range
14% to 48%), and 53 patients had regional wall motion
abnormalities (involving the inferior segments in 40). Coronary
angiograms (65 patients) showed normal coronary arteries
(cardiomyopathy) in 19 patients and coronary artery occlusive
disease in 46. The mean tricuspid regurgitant velocity was
3.0 6 0.5 m/s, and the mean calculated systolic pulmonary
artery pressure was 51 6 14 mm Hg, with a wide range of
variation (23 to 87 mm Hg). The mean cardiac index was 2.46
0.5 liters/min per m2 (range 1.2 to 4.0). As seen in Table 1, the
large standard deviations showed a wide variability in the
hemodynamic and morphologic profiles observed.
Patients with pulmonary hypertension. Marked pulmo-
nary hypertension was defined as a calculated systolic pulmo-
nary artery pressure $50 mm Hg, and the patients were
classified into two groups: those with a pressure $50 mm Hg
(55 patients) and those with a lower pressure (47 patients). The
comparison between the two groups with regard to clinical and
hemodynamic variables and the correlations with pulmonary
artery pressure are presented in Table 1. The results show that
numerous clinical and hemodynamic variables were different in
the two groups of patients and correlated significantly with the
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degree of pulmonary hypertension. An important result is that
the variability of the pulmonary artery pressure is not caused
only by variations of the cardiac index because the correlation
between these two variables is weak and, more important,
negative, showing that the patients with the highest pulmonary
artery pressure tended to have the lowest cardiac index.
In multivariate analysis using category 1 variables (degree
of mitral regurgitation), only the effective regurgitant orifice
remained significant (p 5 0.0001 in both quantitative Doppler
and quantitative two-dimensional echocardiographic models).
In using category 2 (diastolic filling) variables, only decelera-
tion time (p 5 0.0001) remained significant. The results of the
multivariate analysis, including the selected (p , 0.15) vari-
ables of all categories, are presented in Table 2. In all models,
Table 1. Clinical and Hemodynamic Baseline Characteristics and Correlates of
Pulmonary Hypertension
Overall
(n 5 102)
SPAP
Correlation to
SPAP
$50 mm Hg
(n 5 55)
,50 mm Hg
(n 5 47)
p
Value
r
Value
p
Value
Age (yr) 68 6 13 70 6 10 66 6 15 0.08 0.30 0.002
% male 68 78 55 0.015 20.24 0.016
AF (%) 26 31 21 0.27 0.12 0.21
EDVI (ml/m2) 143 6 48 153 6 51 131 6 40 0.022 0.19 0.052
ESVI (ml/m2) 102 6 45 111 6 48 90 6 37 0.014 0.20 0.040
EF (%) 30 6 9 28 6 9 33 6 9 0.012 20.23 0.020
Reg vol (ml/beat)
Doppler echo 22 6 14 27 6 14 17 6 12 0.0004 0.41 0.0001
2D echo 20 6 13 24 6 13 15 6 10 0.0001 0.43 0.0001
RF (%)
Doppler echo 27 6 14 32 6 13 21 6 12 0.0001 0.48 0.0001
2D echo 25 6 14 30 6 13 19 6 12 0.0001 0.46 0.0001
ERO (mm2)
Doppler echo 16 6 12 21 6 13 11 6 9 0.0001 0.50 0.0001
2D echo 15 6 12 20 6 13 9 6 8 0.0001 0.50 0.0001
CI (liters/min per m2) 2.4 6 0.5 2.3 6 0.5 2.5 6 0.5 0.03 20.24 0.016
E wave (cm/s) 86 6 31 93 6 26 79 6 35 0.022 0.28 0.0042
A wave (cm/s) 56 6 29 48 6 30 64 6 24 0.016 20.33 0.0044
E/A ratio 2.2 6 2.3 3.0 6 2.7 1.4 6 1.3 0.0017 0.45 0.0001
DT (ms) 164 6 55 131 6 27 202 6 54 0.0001 20.61 0.0001
LA vol (ml) 111 6 52 123 6 41 97 6 59 0.01 0.34 0.0005
HR (beats/min) 81 6 15 82 6 13 79 6 18 0.33 0.13 0.19
Data presented are mean value 6 SD or percent of patients. AF 5 atrial fibrillation; CI 5 cardiac index; DT 5
deceleration time; echo 5 echocardiography; EDVI 5 end-diastolic volume index; EF 5 ejection fraction; ERO 5
effective regurgitant orifice; ESVI5 end-systolic volume index; HR5 heart rate; LA5 left atrium; Reg vol5 regurgitant
volume; RF 5 regurgitant fraction; SPAP 5 systolic pulmonary artery pressure; 2D 5 two-dimensional.
Table 2. Results of Multivariate Analysis
Variable
Multivariate Analysis
(p value) Effect of Specific Hemodynamic Changes on SPAP
Rank
Model Linear Model
Threshold for
Variable
Abnormality Present
(mm Hg)
Abnormality Absent
(mm Hg)
OR of PHT
(95% CI)
Models using quantitative Doppler echo
DT 0.0001 0.0001 #150 ms 59 6 11 40 6 10 48.8 (14.8–161)
ERO 0.0002 0.0001 $20 mm2 59 6 13 46 6 13 5.9 (2.3–15.5)
Age 0.037 0.01
R2 5 0.52 R2 5 0.50
Models using quantitative 2D echo
DT 0.0001 0.0001
ERO 0.0001 0.0001 $20 mm2 61 6 11 47 6 14 13.1 (3.6–47.4)
Age 0.019 0.006
R2 5 0.53 R2 5 0.50
CI 5 confidence interval; OR 5 odds ratio; PHT 5 pulmonary hypertension; other abbreviations as in Table 1.
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the degree of left ventricular dysfunction was not indepen-
dently predictive of pulmonary artery pressure (Fig. 1), and the
independent predictors of the systolic pulmonary artery pres-
sure were mitral deceleration time (Fig. 2), effective regurgi-
tant orifice of the functional mitral regurgitation (Fig. 3) and
age. The R2 value of these regressions was ;0.50. Similar
results were obtained in univariate and multivariate analyses
when the tricuspid regurgitant velocity was used instead of the
calculated systolic pulmonary artery pressure. Similar results
were also obtained with nonlinear regression by replacing the
deceleration time by its inverse value or its log. No significant
difference of the paired residuals was noted. When stratified
according to the presence of coronary artery occlusive disease,
no difference was found in the predictors of systolic pulmonary
artery pressure.
Discussion
The present study shows that in patients with left ventricu-
lar dysfunction, the degree of pulmonary hypertension calcu-
lated using the Doppler measured maximal tricuspid regurgi-
tant velocity 1) is widely variable; 2) is not independently
determined by the degree of left ventricular dysfunction; and
3) is independently related to the degree of functional mitral
regurgitation as measured by the effective regurgitant orifice
and to the diastolic left ventricular function as assessed by the
mitral deceleration time.
Pulmonary hypertension in patients with left ventricular
dysfunction. Increased pulmonary artery pressures in patients
with left ventricular dysfunction are markers of poor prognosis,
whether the measurements are made invasively (6) or by
Doppler echocardiography (7). Pulmonary hypertension is also
associated with more frequent episodes of congestive heart
failure (7) and even with excess mortality after heart transplan-
tation (8). Therefore, it is essential to comprehend the deter-
minants of this dismal complication of left ventricular dysfunc-
tion.
Pulmonary hypertension may result from an increase in left
atrial pressure (12) and pulmonary resistance (10) and, possi-
bly, from the loss of endothelium-dependent vasodilation of
the pulmonary arterial bed (34). Pulmonary hypertension is
also associated with neurohumoral activation (35,36), in par-
ticular of endothelin-1 (11), a potent vasoconstrictor that is
increased markedly in advanced heart failure (37). Therefore,
the respective roles of cardiac and vascular dysfunction in the
genesis of pulmonary hypertension associated with left ventric-
ular dysfunction are not fully clarified. The present series
demonstrates that specific cardiac abnormalities are strongly
associated with the degree of pulmonary hypertension. Multi-
ple hemodynamic variables were correlated with systolic pul-
monary artery pressure, but remarkably in multivariate analy-
sis, there was no independent effect of the degree of left
ventricular dysfunction expressed either as the ejection frac-
tion or as the end-systolic volume. Only two types of hemody-
namic abnormalities were independent predictors of systolic
pulmonary artery pressure, namely, the degree of functional
mitral regurgitation (effective regurgitant orifice) and, more
important, the degree of diastolic left ventricular dysfunction
(mitral deceleration time).
Figure 1. Correlations between systolic pulmonary artery pressure (S
PAP) (dependent variable) and systolic left ventricular function, as
measured by ejection fraction (EF) (left), and end-systolic volume
index (ESVI) (right) as independent variables.
Figure 2. Correlation between systolic pulmonary artery pressure (S
PAP) (dependent variable) and diastolic left ventricular function, as
measured by deceleration time, as independent variable.
Figure 3. Correlations between systolic pulmonary artery pressure (S
PAP) (dependent variable) and degree of functional mitral regurgita-
tion (measured as the effective regurgitant orifice [ERO]) using
quantitative Doppler (left) and quantitative two-dimensional (2D)
echocardiography (right) as independent variables.
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Diastolic left ventricular dysfunction. The diastolic func-
tion of the left ventricle is a complex phenomenon (38) and is
difficult to analyze, although its role in heart failure has long
been emphasized (39). The active phase of diastole, relaxation,
tends to be prolonged with age (39,40), hypertrophy and
diseases of the left ventricle (39). With Doppler echocardiog-
raphy, prolonged relaxation is diagnosed by the combination of
decreased E wave velocity, increased A wave velocity and
decreased E/A ratio in sinus rhythm and prolonged decelera-
tion time (23,38). In the present study, the features of pro-
longed relaxation were not associated with pulmonary hyper-
tension (12,14), which is consistent with the low diastolic left
ventricular early filling pressure and pulmonary wedge pres-
sure (23) observed with this pattern.
The major marker of pulmonary hypertension was, in the
present study, the restrictive left ventricular filling pattern,
whose hallmark on Doppler echocardiography is a short
deceleration time of the mitral E wave (41), usually with an
increased E/A ratio (23,41,42). Hemodynamically, the short
deceleration time is associated with high diastolic left ventric-
ular pressure (43), increasing steeply in early diastole (23,41),
and it is due to the rapid equilibration of pressure between the
left ventricle and atrium (44). High left ventricular diastolic
and left atrial pressures are usually concomitant (45), but
recent theoretic (25) and experimental (46) data suggest that
the short deceleration time, although associated with increased
left atrial pressure, mostly reflects reduced global left atrial
and ventricular compliance. This reduced global atrial and
ventricular compliance is not due to the inability of the left
atrium or left ventricle to dilate, because in the present study,
their volumes were larger in patients with pulmonary hyper-
tension than in those with lower pressures. These changes
contrast with the small left ventricular volumes observed in
restrictive cardiomyopathy (47).
With regard to prognosis, the restrictive left ventricular
filling pattern has been associated with a poor survival in
amyloidosis (48), but in left ventricular dysfunction, such an
independent effect has usually (12,14,49–52) but not uniformly
(13) been reported and deserves analysis in future large
prospective studies. This variability may be related to the
transient nature of the restrictive filling, which can disappear,
in parallel to pulmonary hypertension, after volume depletion
(53). However, this filling pattern is associated in various
diseases with the occurrence of heart failure (12–14,54) and, in
the present study, was strongly associated, independently of its
frequent coexistence with functional mitral regurgitation (12–
14), with pulmonary hypertension complicating left ventricular
dysfunction.
Functional mitral regurgitation. Functional mitral regur-
gitation (i.e., associated with left ventricular dysfunction) has
been poorly characterized because of 1) the shortcomings of
clinical assessment with frequent silent regurgitation (55); and
2) the limitations of angiographic (56) or color flow Doppler
(57) grading of the degree of regurgitation. Limited quantita-
tive data have demonstrated that functional mitral regurgita-
tion is sensitive to manipulations of loading conditions (58)
and, in particular, is improved by vasodilators (59). Mitral
regurgitation may even be a marker, in left ventricular dysfunc-
tion, of positive response to vasodilators (60,61). The volume
of functional mitral regurgitation is usually less than that in
organic mitral regurgitation (28). However, functional mitral
regurgitation may be a marker of poor prognosis (62) and may
induce left ventricular volume overload (28,63), which in turn
may affect diastolic filling. The results of the present study, to
our knowledge the first to analyze in large numbers of patients
the impact of quantitatively measured functional mitral regur-
gitation, underscore the clinical significance of functional
mitral regurgitation, which may not be recognized because of
the low intensity of murmurs (55), and the importance of its
Doppler quantitation, particularly with new and easily appli-
cable techniques (64). These results also warrant further
analysis of the role of quantified functional mitral regurgitation
in the outcome of patients with left ventricular dysfunction.
Limitations of the study. Pulmonary pressure was calcu-
lated noninvasively by Doppler echocardiography and not
measured by catheterization. The noninvasive method has
been fully validated (20) and currently represents a standard
approach to pulmonary hypertension (65). The potential lim-
itations due to the estimation of right atrial pressure did not
affect the results of the present study, which were similar
whether tricuspid regurgitant velocity or calculated pulmonary
pressure was used. By avoiding the potential selection bias of
catheterization, Doppler echocardiography has the advantage
of analyzing a group of patients representative of those seen
routinely for congestive heart failure. The Doppler diagnosis
of pulmonary hypertension using tricuspid regurgitant velocity
is a powerful prognostic indicator in left ventricular dysfunc-
tion (7) and thus represents a valid end point.
The value of quantitative Doppler echocardiographic meth-
ods has been disputed. Quantitation of regurgitation with
quantitative Doppler has been criticized but with consistent
use provides accurate results (27). Echocardiographically de-
rived left ventricular volumes have been considered to under-
estimate true volumes, but with the current high resolution
imaging, they have proved to be accurate (66). The consistency
of the results obtained with the two methods of quantitation of
regurgitation further confirms the relation of functional mitral
regurgitation with pulmonary hypertension in patients with left
ventricular dysfunction. The Doppler echocardiographic anal-
ysis of left ventricular filling, although reproducible (67), is
arduous to comprehend (23–25), but the understanding of its
pathophysiologic significance is continuously being improved
(46). Therefore, Doppler echocardiographic methods do not
represent a limitation of the present study.
Conclusions. Pulmonary hypertension is a frequent com-
plication of left ventricular dysfunction, but it is highly variable.
The degree of pulmonary hypertension is not independently
related to the degree of left ventricular dysfunction but is
independently associated with the restrictive left ventricular
diastolic filling pattern and with the degree of functional mitral
regurgitation. Future studies regarding the impact of these
hemodynamic variables on the outcome of patients with left
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ventricular dysfunction are warranted. Complementary to the
classic variables of systolic left ventricular function, such as
ejection fraction, the Doppler echocardiographic assessment
of diastolic function and quantitation of mitral regurgitation
provide essential information and should be included routinely
in the clinical evaluation of patients with left ventricular dys-
function.
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